AlphaValue/Baader analyst Rishabh Kochar upgraded GSK to Buy from Add.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on GSK:
- GSK says PERLA ph. 2 trial achieved ‘very promising results’ on primary endpoint
- GSK says court has dismissed all cases alleging five remaining cancers in MDL
- Florida district court grants Sanofi, GSK summary judgment of Zantac suits
- GSK, Sanofi higher after U.S. court win related to Zantac, Bloomberg says
- GSK, Sanofi jump in afternoon trading